- Home
- STRW vs THTX Comparison
STRW vs THTX Comparison
Compare STRW & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRW
- THTX
- Stock Information
- Founded
- STRW 2015
- THTX 1993
- Country
- STRW United States
- THTX Canada
- Employees
- STRW N/A
- THTX N/A
- Industry
- STRW Real Estate Investment Trusts
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- STRW Real Estate
- THTX Health Care
- Exchange
- STRW Nasdaq
- THTX Nasdaq
- Market Cap
- STRW 133.6M
- THTX 118.2M
- IPO Year
- STRW N/A
- THTX N/A
- Fundamental
- Price
- STRW $10.15
- THTX $2.62
- Analyst Decision
- STRW Strong Buy
- THTX Hold
- Analyst Count
- STRW 4
- THTX 1
- Target Price
- STRW $13.83
- THTX N/A
- AVG Volume (30 Days)
- STRW 45.5K
- THTX 6.2M
- Earning Date
- STRW 05-09-2025
- THTX 04-09-2025
- Dividend Yield
- STRW 5.47%
- THTX N/A
- EPS Growth
- STRW 34.22
- THTX N/A
- EPS
- STRW 0.58
- THTX N/A
- Revenue
- STRW $126,557,000.00
- THTX $88,666,000.00
- Revenue This Year
- STRW $15.21
- THTX N/A
- Revenue Next Year
- STRW $2.21
- THTX $15.13
- P/E Ratio
- STRW $17.34
- THTX N/A
- Revenue Growth
- STRW 22.41
- THTX 13.52
- 52 Week Low
- STRW $8.70
- THTX $1.08
- 52 Week High
- STRW $12.90
- THTX $3.13
- Technical
- Relative Strength Index (RSI)
- STRW 41.28
- THTX 57.56
- Support Level
- STRW $10.00
- THTX $2.64
- Resistance Level
- STRW $11.50
- THTX $2.82
- Average True Range (ATR)
- STRW 0.68
- THTX 0.17
- MACD
- STRW -0.06
- THTX -0.04
- Stochastic Oscillator
- STRW 15.09
- THTX 20.45
About STRW Strawberry Fields REIT Inc.
Strawberry Fields REIT Inc is a self-managed and self-administered company that specializes in the acquisition, ownership and triple-net leasing of skilled nursing facilities and other post-acute healthcare properties.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.